167 related articles for article (PubMed ID: 15289283)
1. Novel diacylglycerol kinase inhibitor selectively suppressed an U46619-induced enhancement of mouse portal vein contraction under high glucose conditions.
Nobe K; Miyatake M; Nobe H; Sakai Y; Takashima J; Momose K
Br J Pharmacol; 2004 Sep; 143(1):166-78. PubMed ID: 15289283
[TBL] [Abstract][Full Text] [Related]
2. Enhancement effect under high-glucose conditions on U46619-induced spontaneous phasic contraction in mouse portal vein.
Nobe K; Sakai Y; Nobe H; Takashima J; Paul RJ; Momose K
J Pharmacol Exp Ther; 2003 Mar; 304(3):1129-42. PubMed ID: 12604690
[TBL] [Abstract][Full Text] [Related]
3. Glucose-dependent enhancement of spontaneous phasic contraction is suppressed in diabetic mouse portal vein: association with diacylglycerol-protein kinase C pathway.
Nobe K; Suzuki H; Sakai Y; Nobe H; Paul RJ; Momose K
J Pharmacol Exp Ther; 2004 Jun; 309(3):1263-72. PubMed ID: 14988417
[TBL] [Abstract][Full Text] [Related]
4. High-glucose enhances a thromboxane A2-induced aortic contraction mediated by an alteration of phosphatidylinositol turnover.
Nobe K; Suzuki H; Nobe H; Sakai Y; Momose K
J Pharmacol Sci; 2003 Jul; 92(3):267-82. PubMed ID: 12890893
[TBL] [Abstract][Full Text] [Related]
5. High-glucose-altered endothelial cell function involves both disruption of cell-to-cell connection and enhancement of force development.
Nobe K; Miyatake M; Sone T; Honda K
J Pharmacol Exp Ther; 2006 Aug; 318(2):530-9. PubMed ID: 16699065
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the involvement of protein kinase C in agonist-induced contractions in mouse aorta and corpus cavernosum.
Jin L; Teixeira CE; Webb RC; Leite R
Eur J Pharmacol; 2008 Aug; 590(1-3):363-8. PubMed ID: 18614166
[TBL] [Abstract][Full Text] [Related]
7. Selective and potent inhibitory effect of docosahexaenoic acid (DHA) on U46619-induced contraction in rat aorta.
Sato K; Chino D; Kobayashi T; Obara K; Miyauchi S; Tanaka Y
J Smooth Muscle Res; 2013; 49():63-77. PubMed ID: 24304639
[TBL] [Abstract][Full Text] [Related]
8. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
9. Difference in signal transduction mechanisms involved in 5-hydroxytryptamine- and U46619-induced vasoconstrictions.
Tasaki K; Hori M; Ozaki H; Karaki H; Wakabayashi I
J Smooth Muscle Res; 2003 Oct; 39(5):107-17. PubMed ID: 14695024
[TBL] [Abstract][Full Text] [Related]
10. Diacylglycerol regulates acute hypoxic pulmonary vasoconstriction via TRPC6.
Fuchs B; Rupp M; Ghofrani HA; Schermuly RT; Seeger W; Grimminger F; Gudermann T; Dietrich A; Weissmann N
Respir Res; 2011 Feb; 12(1):20. PubMed ID: 21294865
[TBL] [Abstract][Full Text] [Related]
11. Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro.
Kemp BK; Cocks TM
Br J Pharmacol; 1995 Oct; 116(4):2183-90. PubMed ID: 8564247
[TBL] [Abstract][Full Text] [Related]
12. Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619.
Cocks TM; Kemp BK; Pruneau D; Angus JA
Br J Pharmacol; 1993 Sep; 110(1):360-8. PubMed ID: 8220898
[TBL] [Abstract][Full Text] [Related]
13. Possible role of atypical protein kinase C activated by arachidonic acid in Ca2+ sensitization of rabbit smooth muscle.
Gailly P; Gong MC; Somlyo AV; Somlyo AP
J Physiol; 1997 Apr; 500 ( Pt 1)(Pt 1):95-109. PubMed ID: 9097936
[TBL] [Abstract][Full Text] [Related]
14. Signalling pathway of U46619-induced vascular smooth muscle contraction in mouse coronary artery.
Jiang RS; Zhang L; Yang H; Zhou MY; Deng CY; Wu W
Clin Exp Pharmacol Physiol; 2021 Jul; 48(7):996-1006. PubMed ID: 33792963
[TBL] [Abstract][Full Text] [Related]
15. Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
Pfister SL; Pratt PE; Kurian J; Campbell WB
Vascul Pharmacol; 2004 Jan; 40(6):285-92. PubMed ID: 15063832
[TBL] [Abstract][Full Text] [Related]
16. Intracellular calcium and myosin light chain phosphorylation during U46619-activated vascular contraction.
Jiang MJ; Chan CF; Chang YL
Life Sci; 1994; 54(25):2005-13. PubMed ID: 7515455
[TBL] [Abstract][Full Text] [Related]
17. Role of voltage-dependent and Ca(2+)-activated K(+) channels on the regulation of isometric force in porcine coronary artery.
Shimizu S; Yokoshiki H; Sperelakis N; Paul RJ
J Vasc Res; 2000; 37(1):16-25. PubMed ID: 10720882
[TBL] [Abstract][Full Text] [Related]
18. Peroxide generation by p47phox-Src activation of Nox2 has a key role in protein kinase C-induced arterial smooth muscle contraction.
Gupte SA; Kaminski PM; George S; Kouznestova L; Olson SC; Mathew R; Hintze TH; Wolin MS
Am J Physiol Heart Circ Physiol; 2009 Apr; 296(4):H1048-57. PubMed ID: 19168729
[TBL] [Abstract][Full Text] [Related]
19. Specific attenuation of the pressure-induced contraction of rat cerebral artery by herbimycin A.
Masumoto N; Nakayama K; Oyabe A; Uchino M; Ishii K; Obara K; Tanabe Y
Eur J Pharmacol; 1997 Jul; 330(1):55-63. PubMed ID: 9228414
[TBL] [Abstract][Full Text] [Related]
20. The pore-forming subunit of the K(ATP) channel is an important molecular target for LPS-induced vascular hyporeactivity in vitro.
O'Brien AJ; Thakur G; Buckley JF; Singer M; Clapp LH
Br J Pharmacol; 2005 Feb; 144(3):367-75. PubMed ID: 15655519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
